These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11561486)

  • 21. Facioscapulohumeral muscular dystrophy molecular testing using a non radioactive protocol.
    Kekou K; Fryssira H; Sophocleous C; Mavrou A; Manta P; Metaxotou C
    Mol Cell Probes; 2005 Dec; 19(6):422-4. PubMed ID: 16144755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facioscapulohumeral dystrophy.
    Pandya S; King WM; Tawil R
    Phys Ther; 2008 Jan; 88(1):105-13. PubMed ID: 17986494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facioscapulohumeral muscular dystrophy.
    Padberg GW; van Engelen BG
    Curr Opin Neurol; 2009 Oct; 22(5):539-42. PubMed ID: 19724227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facioscapulohumeral muscular dystrophy with severe mental retardation and epilepsy.
    Saito Y; Miyashita S; Yokoyama A; Komaki H; Seki A; Maegaki Y; Ohno K
    Brain Dev; 2007 May; 29(4):231-3. PubMed ID: 17010549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facioscapulohumeral muscular dystrophy presenting as shoulder pain in a baseball player.
    Kaar S; Hazard D; Miller BS
    Arthroscopy; 2005 Sep; 21(9):1145. PubMed ID: 16171643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A patient with facioscapulohumeral muscular dystrophy accompanied by myasthenia gravis].
    Sakuma H; Shimazaki S; Saito H; Ohuchi M
    Rinsho Shinkeigaku; 2001; 41(4-5):179-83. PubMed ID: 11676158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alveolar hypoventilation as an early symptom of muscle weakness in facioscapulohumeral muscular dystrophy.
    Rupprecht S; Hagemann G; Witte OW; Schwab M
    Sleep Med; 2009 May; 10(5):592-3. PubMed ID: 18753002
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
    Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
    Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysphagia in facioscapulohumeral muscular dystrophy.
    Wohlgemuth M; de Swart BJ; Kalf JG; Joosten FB; Van der Vliet AM; Padberg GW
    Neurology; 2006 Jun; 66(12):1926-8. PubMed ID: 16801662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Unique Case of Type-1 Facioscapulohumeral Muscular Dystrophy and Sarcomeric Hypertrophic Cardiomyopathy.
    Lima da Silva G; Guimarães T; Pinto FJ; Brito D
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):765-766. PubMed ID: 28697927
    [No Abstract]   [Full Text] [Related]  

  • 34. Facioscapulohumeral muscular dystrophy presenting isolated monomelic lower limb atrophy. Report of two patients with and without 4q35 rearrangement.
    Uncini A; Galluzzi G; Di Muzio A; De Angelis MV; Ricci E; Scoppetta C; Servidei S
    Neuromuscul Disord; 2002 Nov; 12(9):874-7. PubMed ID: 12398841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affection of mimic muscles, simulating damage of the facial nerve in patients with facioscapulohumeral muscular dystrophy.
    Kazakov VM
    Eur Arch Otorhinolaryngol; 1994 Dec; ():S96-101. PubMed ID: 10774323
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
    Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
    J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical facioscapulohumeral muscular dystrophy masquerading as bilateral Coats disease in a woman.
    Vance SK; Wald KJ; Sherman J; Freund KB
    Arch Ophthalmol; 2011 Jun; 129(6):807-9. PubMed ID: 21670353
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel mitochondrial tRNA Leu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype.
    Filosto M; Tonin P; Scarpelli M; Savio C; Greco F; Mancuso M; Vattemi G; Govoni V; Rizzuto N; Tupler R; Tomelleri G
    Neuromuscul Disord; 2008 Mar; 18(3):204-9. PubMed ID: 18343111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facioscapulohumeral muscular dystrophy.
    Fitzsimons RB
    Curr Opin Neurol; 1999 Oct; 12(5):501-11. PubMed ID: 10590886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.